TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 36 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $267,000 | -37.6% | 134,293 | -3.5% | 0.00% | -50.0% |
Q1 2014 | $428,000 | -9.5% | 139,150 | -1.2% | 0.00% | 0.0% |
Q4 2013 | $473,000 | +54.1% | 140,772 | +45.3% | 0.00% | 0.0% |
Q3 2013 | $307,000 | +10.8% | 96,858 | +5.5% | 0.00% | +100.0% |
Q2 2013 | $277,000 | – | 91,801 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roumell Asset Management, LLC | 1,942,184 | $3,865,000 | 4.53% |
NEA Management Company, LLC | 2,086,755 | $4,153,000 | 0.20% |
BVF INC/IL | 150,000 | $299,000 | 0.05% |
ABNER HERRMAN & BROCK LLC | 20,000 | $40,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 137,000 | $273,000 | 0.01% |
Spark Investment Management LLC | 16,100 | $32,000 | 0.01% |
CSS LLC/IL | 20,420 | $41,000 | 0.00% |
Waverly Advisors, LLC | 2,670 | $5,000 | 0.00% |
PANAGORA ASSET MANAGEMENT INC | 134,293 | $267,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 466,573 | $928,000 | 0.00% |